@article{MTMT:3171881,
 author = {Farkas, Klaudia and Rutka, Mariann and Ferenci, Tamás and Nagy, Ferenc and Bálint, Anita and Bor, Renáta and Milassin, Ágnes and Fábián, Anna and Szepes, Zoltán and Molnár, Tamás},
 eissn = {2050-6414},
 issn = {2050-6406},
 journal = {UNITED EUROPEAN GASTROENTEROLOGY JOURNAL},
 journal-iso = {UEG JOURNAL},
 orcid-numbers = {Farkas, Klaudia/0000-0003-0599-182X; Rutka, Mariann/0000-0003-2360-7836; Ferenci, Tamás/0000-0001-6791-3080; Bálint, Anita/0000-0002-3624-896X; Bor, Renáta/0000-0001-9393-5240; Milassin, Ágnes/0000-0001-6902-8915; Fábián, Anna/0000-0002-0824-7476; Szepes, Zoltán/0000-0002-9466-8719; Molnár, Tamás/0000-0002-4913-7599},
 pages = {A645-A645},
 title = {Infliximab biosimilar CT-P13 therapy is effective in maintaining clinical and endoscopic remission in Crohn’s disease and ulcerative colitis – experiences from a single center},
 unique-id = {3171881},
 url = {https://m2.mtmt.hu/api/publication/3171881},
 volume = {4},
 year = {2016}
}
